Equities

Innovotech Inc

IOT:CVE

Innovotech Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)0.150
  • Today's Change0.00 / 0.00%
  • Shares traded43.60k
  • 1 Year change+42.86%
  • Beta1.2684
Data delayed at least 15 minutes, as of Nov 11 2024 19:24 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Innovotech Inc. is a Canadian biotechnology company. The Company is engaged in owning intellectual property, conducting contract research, and owning and providing devices for testing in multiple applications in microbiology. Its contract research services include Antimicrobial Contract Research; Antimicrobial and Anti-Biofilm Agents, including Minimum Inhibitory Concentration (MIC) and Minimum Biofilm; Eradication Concentration (MBEC); Antimicrobial and Anti-Biofilm Materials, including TM100, ISO 22196 and USP 51; Customized Antimicrobial Testing, including BEST Assay Testing and Implanted Medical Device Testing; Bacteriophage Testing; and Analytical Capabilities. It also offers MBEC Assay Kits, Order Biofilm Assays and Coated MBEC Assay Lids. Its biofilm research includes The Science of Biofilms, Biofilm Publications and SEM Library. Its antimicrobial silver products include AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products.

  • Revenue in CAD (TTM)1.23m
  • Net income in CAD-364.50k
  • Incorporated2006
  • Employees16.00
  • Location
    Innovotech Inc2011 94 St NW Suite 101EDMONTON T6N 1H1CanadaCAN
  • Phone+1 (780) 448-0585
  • Fax+1 (780) 424-0941
  • Websitehttps://innovotech.ca/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
IOT:CVE since
announced
Transaction
value
Keystone Labs IncDeal completed11 Sep 202411 Sep 2024Deal completed15.38%380.00k
Data delayed at least 15 minutes, as of Nov 11 2024 19:24 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Appili Therapeutics Inc827.41k-3.82m4.24m7.00------5.13-0.0315-0.03150.0068-0.10210.3758--0.6463118,201.40-173.36-128.44---251.87-----461.35-2,103.81---3.30----147.59--59.09--17.59--
StageZero Life Sciences Ltd-100.00bn-100.00bn4.92m40.00---------------0.1212-----------135.76-------2.74---246.920.0204-------25.1255.93-52.53------
Quest PharmaTech Inc0.0013.58m5.07m0.000.37370.22050.3737--0.08030.08030.000.1360.00------53.307.6255.608.45------------0.04170.00----95.35------
XORTX Therapeutics Inc0.00-2.07m5.43m3.00--1.44-----0.6985-0.69850.001.300.00-------23.54-35.42-29.36-40.37------------0.03------72.04--7.91--
Innovotech Inc1.23m-364.50k6.13m16.00--8.02--4.99-0.0094-0.00940.03150.01871.105.815.84---32.592.90-37.993.5668.6371.56-29.672.192.17--0.1115--5.057.42-15.43--35.69--
Principal Technologies Inc618.64k-1.90m6.27m----10.33--10.13-0.0766-0.07660.02460.01650.5664--2.92---170.72---445.11--21.57---301.45-----31.950.0959--25.43--23.53------
Marvel Biosciences Corp0.00-2.10m6.27m-----------0.0529-0.05290.00-0.06930.00-------268.48-----------------14.33--------10.29------
Rakovina Therapeutics Inc0.00-2.94m7.22m----1.77-----0.0419-0.04190.000.04520.00-------46.65---51.51-------------13.010.2652------6.39------
Medicure Inc20.93m-2.63m9.18m25.00--0.47--0.4388-0.2529-0.25291.941.870.72882.284.38837,280.00-9.16-13.42-12.73-18.2861.4161.87-12.56-27.381.42--0.0202---5.94-5.71-167.55---28.82--
Data as of Nov 11 2024. Currency figures normalised to Innovotech Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.